Natco Pharma Ltd share price logo

Natco Pharma Share Price

NSE: NATCOPHARM

BSE: 524816

Small Cap

Healthcare Sector

₹956.25

-32.25

(-3.26%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

🔔 Product Launch Alert

Natco Pharma launches Pomalidomide capsules in the U.S. market, marking a significant product expansion.

Natco Pharma Stock Performance

as on March 2, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹925.15
    ₹967.85
    downward going graph

    3.25%

    Downside

    1.21%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹726.80
    ₹1,059.00
    downward going graph

    23.99%

    Downside

    10.75%

    Upside

    downward going graph

Natco Pharma share price movements today

Previous Close
₹988.50
Open
₹925.15
Volume
10.73L
Upper Circuit
₹1,186.20
Lower Circuit
₹790.80
Day's Low - High
₹925.15 - ₹967.85
52 Week Low - High
₹726.80 - ₹1,059.00

Natco Pharma Historical Returns

1 Month Return
+ 12.01 %
3 Month Return
+ 2.23 %
1 Year Return
+ 20.18 %
3 Year Return
+ 70.06 %
5 Year Return
+ 18.9 %

Natco Pharma Fundamentals

as on March 2, 2026 at 4:01 pm IST

Market Cap

₹17,127.38 Cr

Return on Equity (ROE)

28.63

PE Ratio (TTM)

11

Return on capital employed (ROCE)

32.75

Industry PE ratio

42.16

Beta (LTM)

0

P/B Ratio

1.95

Dividend Yield

0.75

PEG Ratio

-0.64

Quarterly Earnings Growth YOY

6.04

EPS (TTM)

105.22

Sector

Pharmaceuticals

Book Value

424.97

Technical Analysis

Bullish

View Technical Analysis

Natco Pharma Stock Valuation

as on March 2, 2026 at 4:01 pm IST

Natco Pharma in the last 5 years

  • Overview

  • Trends

Lowest (7.09x)

April 9, 2025

Today (11.00x)

March 2, 2026

Industry (42.16x)

March 2, 2026

Highest (90.32x)

April 6, 2022

LowHigh

Today’s Price to Earnings Ratio: 11.00x

Natco Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Natco Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Natco Pharma Ltd image
Natco Pharma Ltd
HOLD17,127.383.78%0.521,8834,429
Sanofi India Ltd image
Sanofi India Ltd
BUY8,888.43-10.69%0.524132,013
Aurobindo Pharma Ltd image
Aurobindo Pharma Ltd
BUY70,300.237.49%0.603,48331,723
Zydus Lifesciences Ltd image
Zydus Lifesciences Ltd
HOLD91,255.3620.7%0.614,61423,241
Abbott India Ltd image
Abbott India Ltd
BUY56,960.6316.68%0.001,4146,445
See all

Market expectation of Natco Pharma Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

HOLD

30.00%

Buy

40.00%

Hold

30.00%

Sell

Natco Pharma Stock’s Investor Sentiment and Interest

Investment in Natco Pharma Ltd Shares on INDmoney has grown by 69.63% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:69.63% versus previous 30 day period

Search interest for Natco Pharma Ltd Stock has increased by 50% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:50% versus previous 30 day period

Natco Pharma Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
897.9
1,140.5
1,031.4
758.6
1,068.3
1,362.6
1,371.1
474.8
1,221
1,328.9
1,363
647.3
Other Income
29
19.7
29.4
37
42
48.1
63.8
176.3
66.3
61.7
100
58.1
Total Income
926.9
1,160.2
1,060.8
795.6
1,110.3
1,410.7
1,434.9
651.1
1,287.3
1,390.6
1,463
705.4
Expenses
558.8
612.5
573.4
490.5
571
557.8
566.8
436
672.9
757.9
783.8
488.6
Operating Profit
339.1
528
458
268.1
497.3
804.8
804.3
38.8
548.1
571
579.2
158.7
Operating Profit Margin %
37.77%
46.3%
44.41%
35.34%
46.55%
59.06%
58.66%
8.17%
44.89%
42.97%
42.49%
24.52%
Profit Before Interest, Tax and Depreciation
368.1
547.7
487.4
305.1
539.3
852.9
868.1
215.1
614.4
632.7
679.2
216.8
Interest
2.7
4.2
4.2
4.6
6.2
5.2
4.1
4.4
10.2
3.2
13.1
9.5
Depreciation
41
43.5
43.6
44.2
55.5
44.1
45.8
47
98.3
57.6
52.4
46.2
Profit Before Tax
324.4
500
439.6
256.3
477.6
803.6
818.2
163.7
505.9
571.9
613.7
161.1
Tax Paid
48.6
79.7
70.6
43.6
91.3
135.1
141.7
31.3
99.9
91.6
95.8
20.7
Profit After Tax
275.8
420.3
369
212.7
386.3
668.5
676.5
132.4
406
480.3
517.9
140.4
Total Net profit including share of profit / Loss from associate company
275.8
420.3
369
212.7
386.3
668.5
676.5
132.4
406
480.3
517.9
151.3
EPS
15.11
23.26
20.6
11.88
21.56
37.32
37.81
7.43
22.7
26.84
28.94
8.46
Actual EPS
15.11
23.26
20.6
11.88
21.56
37.32
37.81
7.43
22.7
26.84
28.94
8.46
Adjusted EPS
15.11
23.26
20.6
11.88
21.56
37.32
37.81
7.43
22.7
26.84
28.94
8.46
Diluted EPS
15.11
23.26
20.6
11.88
21.56
37.32
37.81
7.43
22.7
26.84
28.94
8.46

Natco Pharma Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
2,020.2
2,184.8
2,094.5
1,915
2,052.1
1,944.8
2,707.1
3,998.8
4,429.5
Other Income
13.9
40.4
130.2
107.4
103.6
99
104.6
128.1
354.5
Total Income
2,034.1
2,225.2
2,224.7
2,022.4
2,155.7
2,043.8
2,811.7
4,126.9
4,784
Expenses
1,336.8
1,256.4
1,299.7
1,332.4
1,445.9
1,681.3
1,771.5
2,247.4
2,233.5
Operating Profit
683.4
928.4
794.8
582.6
606.2
263.5
935.6
1,751.4
2,196
Operating Profit Margin %
33.83%
42.49%
37.95%
30.42%
29.54%
13.55%
34.56%
43.8%
49.58%
Profit Before Interest, Tax and Depreciation
697.3
968.8
925
690
709.8
362.5
1,040.2
1,879.5
2,550.5
Interest
18.5
15.4
19.3
21.5
13.3
17.7
14.5
19.2
23.9
Depreciation
54.4
66.2
81
99.8
116.9
142.6
163.8
186.8
235.2
Profit Before Tax
624.4
887.2
824.7
568.7
579.6
202.2
861.9
1,673.5
2,291.4
Tax Paid
139.5
192
182.3
110.6
137.2
32.2
146.6
285.2
408
Profit After Tax
484.9
695.2
642.4
458.1
442.4
170
715.3
1,388.3
1,883.4
Total Net profit including share of profit / Loss from associate company
484.9
695.2
642.4
458.1
442.4
170
715.3
1,388.3
1,883.4
EPS
27.78
39.26
34.98
25.33
24.2
9.32
39.18
77.34
105.26
Actual EPS
27.78
39.26
34.98
25.33
24.2
9.32
39.18
77.34
105.26
Adjusted EPS
27.78
39.26
34.98
25.33
24.2
9.32
39.18
77.34
105.26
Diluted EPS
27.75
39.13
34.87
25.26
24.16
9.32
39.18
77.34
105.26

Natco Pharma Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
112.2
345.8
463.6
668.8
417.3
298.8
46.5
849.1
1,211.6
1,696.8
Cash Flow from Investing Activities
-176.3
-298.8
-1,116.3
-611.3
-175
-107.1
4
-465.3
-1,026.2
-1,436.5
Cash Flow from Financing Activities
154
-47.7
650.9
-50.9
-250.8
-185.7
34.8
-363
-246.9
-210.7
Net Cash Flow
89.9
-0.7
-1.8
6.6
-8.5
6
85.3
20.8
-61.5
49.6

Natco Pharma Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
49.76%
49.71%
49.71%
49.71%
49.71%
49.62%
49.62%
49.56%
49.56%
49.48%
49.48%
DII
15.02%
14.01%
11.23%
9.7%
7.87%
6.75%
5.57%
5.65%
5.82%
5.87%
5.39%
FII
0%
0%
0%
16.14%
17.45%
17.51%
17.94%
17.49%
15.51%
14.09%
15.16%
Public
24.07%
23.46%
25.32%
24.45%
24.97%
26.12%
26.87%
27.29%
29.11%
30.56%
29.96%
Total Outstanding Shares
17,91,09,870
17,91,09,870
17,91,09,870
17,91,09,870
17,91,09,870
17,91,09,870
17,91,09,870
17,91,09,870
17,91,09,870
17,91,09,870
17,91,09,870
Total Shareholders
1,55,181
1,63,753
2,07,571
2,28,467
2,51,485
3,02,944
3,45,332
4,05,222
4,29,434
4,19,699
4,24,167

Mutual Funds that own Natco Pharma Stock

Check out the Mutual Funds with significant holdings in Natco Pharma.

Natco Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Natco Pharma.

  • Natco Pharma Ltd Earnings Results

    Natco Pharma Ltd’s net profit jumped 13.91% since last year same period to ₹151.50Cr in the Q3 2025-2026. On a quarterly growth basis, Natco Pharma Ltd has generated -70.78% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Natco Pharma Ltd Dividends February,2026

    In the quarter ending December 2025, Natco Pharma Ltd has declared dividend of ₹1.50 per share on 12 Feb 2026 - translating a dividend yield of 0.89%.

    Read More about Dividends

Indices Featuring Natco Pharma Stock

Check stock indices that include Natco Pharma.

Nifty Smallcap 50

₹8,167.25

-1.63 (▲135.05%)

Nifty Small 100

₹16,632.40

-1.75 (▲296.50%)

S&P BSE 400 MidSmallCap

₹11,509.16

-1.74 (▲203.72%)

BSE Healthcare

₹43,744.66

-0.39 (▲172.81%)

S&P BSE 250 SmallCap

₹6,172.61

-1.98 (▲124.74%)

Nifty MidSmallcap 400

₹19,281.25

-1.76 (▲346.25%)

Nifty Smallcap 250

₹15,580.40

-1.89 (▲300.65%)

Nifty 500

₹22,835.95

-1.43 (▲330.90%)

BSE 500

₹35,812.02

-1.41 (▲510.54%)

Insights on Natco Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 14.09% to 15.16% in Dec 2025 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, NATCOPHARM stock has moved up by 12.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 192.6% return, outperforming this stock by 122.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 47.7% return, outperforming this stock by 27.5%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 49.48% of holdings in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 1.46K Cr → 705.4 Cr (in ₹), with an average decrease of 51.8% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 30.56% to 29.96% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 518.4 Cr → 151.5 Cr (in ₹), with an average decrease of 70.8% per quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 2.20% to 1.60% in Dec 2025 quarter

About Natco Pharma Ltd

Natco Pharma Limited is an international, RD focused pharmaceutical company that specialises in the development, manufacturing and marketing of Finished Dosage Formulations (FDF) and Active Pharmaceutical Ingredients (APIs). Natco sells products in over 40 countries, and provides contract manufacturing services for other pharmaceutical companies. The company was originally founded in 1981, and has since enjoyed significant growth, launching a variety of products and earning a number of milestones such as a compulsory license from Bayer for its patent protected anticancer drug Nexavar in 2012, and various first-to-market generic drugs including HEPCINAT (generic Sofosbuvir) and Epclusa (a single tablet regimen for the treatment of genotypes 2 and 3 chronic hepatitis C virus HCV infection). In 2021, Natco had 8 launches in the domestic market and acquired Dash Pharmaceuticals LLC in the US. Natco has 8 international subsidiaries, including the Philippines, Australia, Brazil and the US, constantly achieving the first generic to market for a variety of drugs. Natco's ambition for growth looks set to continue in 2022, with a number of new launches planned.

Revenue: ₹647.30Cr as on December 2025 (Q3 FY26)
Net Profit: ₹140.40Cr as on December 2025 (Q3 FY26)
Listing date: 27 Dec, 1995
Chairperson Name: G S Murthy
OrganisationNatco Pharma Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
CEOG S Murthy
E-voting on sharesClick here to vote

FAQs

What is Natco Pharma share price today?

Natco Pharma share price today stands at ₹956.25 as on at the close of the market. Natco Pharma share today touched a day high of ₹967.85 and a low of ₹925.15.

What is the 52 week high and 52 week low range for Natco Pharma share?

Natco Pharma touched a 52 week high of ₹1059 and a 52 week low of ₹726.8. Natco Pharma share price today i.e. is closed at ₹956.25, which is -9.70% down from its 52 week high and 31.57% up from its 52 week low.

What is Natco Pharma's market capitalisation today?

Natco Pharma market capitalisation is ₹17,127.38 Cr as on .

How to buy Natco Pharma shares?

To buy Natco Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for NATCOPHARM or Natco Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Natco Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Natco Pharma trading volume today?

Natco Pharma trading volume is 10.73L as on . This means that 10.73L shares of Natco Pharma were bought and sold on the stock market during today's trading session.